Anne McDonald Pritchett, PhD
@pritchettpolicy
Founder, Pritchett Policy Associates
Senior Associate, Center for Strategic & International Studies
Innovation policies, biopharma supply chain, US leadership
218 Following 55 Followers
The U.S. tech transfer system and the $3.3 trillion in economic output it has generated wouldn’t exist without the Bayh-Dole Act. Read @SallyPipes' piece in @Forbes:
@RxPricing @axios If we want more affordable alternatives, we should start by addressing PBMs and middlemen that leave patients paying more at the pharmacy counter. We also need to look at how IRA & MFN price controls could be harming incentives for biosimilar investments.
Show more
